Incannex Healthcare IXHL Insider Ownership

NASDAQ IXHL
$3.31 +0.16 (+5.08%)
At close: Sep 29, 2026 · 4:00 PM EDT

Insider Holdings by Owner

390.24K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
3.16%
■0% pp QoQ
Shares Held by Insiders
390.24K
filed for Sep 2026
■0.00% QoQ
Shares Outstanding
12.35Mn
12,348,460 shares
Direct Holdings
390.24K
Indirect: 0
Net Shares Traded (QoQ)
0
no net change in Sep 2026
Insiders Holding Shares
7
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest —
Average ownership —
Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter —
Net over range —
Buying quarters —

Insider Ownership Summary

Quarter ending 30 Sep, 2026

Incannex Healthcare's top three insider shareholders as of September 29, 2026 are Joel Latham (Ceo And President, 201.55K shares), Troy Valentine (Director, 100.02K shares), George Anastassov (Director, 20.47K shares).

Form 4 Holdings

Insiders Holding IXHL

Insiders 7
Shares held 390.24K
Of outstanding 3.16%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Joel Latham Ceo And President 214,697 0 214,697 55.0% 14 Nov, 2025
2 Troy Valentine Director 105,843 0 105,843 27.1% 14 Nov, 2025
3 George Anastassov Director 26,887 0 26,887 6.9% 14 Nov, 2025
4 Peter Widdows Director 18,572 0 18,572 4.8% 14 Nov, 2025
5 Robert Clark Director 15,725 0 15,725 4.0% 14 Nov, 2025
6 Joseph Swan Cfo, Treasurer And Secretary 7,678 0 7,678 2.0% 14 Nov, 2025
7 Luigi M. Barbato Chief Medical Officer 837 0 837 0.2% 24 Oct, 2024

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

12 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
14 Nov, 2025 George Anastassov Director Acquired A 1,686,956 $0.00 $0 20,472 Direct
14 Nov, 2025 Joel Latham Ceo And President Acquired A 22,608,692 $0.00 $0 201,551 Direct
14 Nov, 2025 Joseph Swan Cfo, Treasurer And Secretary Acquired A 869,565 $0.00 $0 7,678 Direct
14 Nov, 2025 Troy Valentine Director Acquired A 11,302,608 $0.00 $0 100,015 Direct
14 Nov, 2025 Peter Widdows Director Acquired A 1,686,956 $0.00 $0 16,315 Direct
14 Nov, 2025 Robert Clark Director Acquired A 1,686,956 $0.00 $0 14,891 Direct
23 Oct, 2024 Luigi M. Barbato Chief Medical Officer Acquired A 100,476 $0.00 $0 837 Direct
21 Dec, 2023 George Anastassov Director Acquired A 100,000 $0.00 $0 6,414 Direct
21 Dec, 2023 Joel Latham Ceo And President Acquired A 1,340,000 $0.00 $0 13,146 Direct
21 Dec, 2023 Troy Valentine Director Acquired A 670,000 $0.00 $0 5,827 Direct
21 Dec, 2023 Peter Widdows Director Acquired A 100,000 $0.00 $0 2,257 Direct
21 Dec, 2023 Robert Clark Director Acquired A 100,000 $0.00 $0 833 Direct